Tissue slice grafts: an in vivo model of human prostate androgen signaling.
We developed a tissue slice graft (TSG) model by implanting thin, precision-cut tissue slices derived from fresh primary prostatic adenocarcinomas under the renal capsule of immunodeficient mice. This new in vivo model not only allows analysis of approximately all of the cell types present in prostate cancer within an intact tissue microenvironment, but also provides a more accurate assessment of the effects of interventions when tissues from the same specimen with similar cell composition and histology are used as control and experimental samples. The thinness of the slices ensures that sufficient samples can be obtained for large experiments as well as permits optimal exchange of nutrients, oxygen, and drugs between the grafted tissue and the host. Both benign and cancer tissues displayed characteristic histology and expression of cell-type specific markers for up to 3 months. Moreover, androgen-regulated protein expression diminished in TSGs after androgen ablation of the host and was restored after androgen repletion. Finally, many normal secretory epithelial cells and cancer cells in TSGs remained viable 2 months after androgen ablation, consistent with similar observations in postprostatectomy specimens following neoadjuvant androgen ablation. Among these were putative Nkx3.1(+) stem cells. Our novel TSG model has the appropriate characteristics to serve as a useful tool to model all stages of disease, including normal tissue, premalignant lesions, well-differentiated cancer, and poorly differentiated cancer.
Zhao
Hongjuan
H
Department of Urology, Stanford University School of Medicine, Stanford, CA 94305-5118, USA.
Nolley
Rosalie
R
Chen
Zuxiong
Z
Peehl
Donna M
DM
D000230:Adenocarcinoma / Q000473:pathology; D000728:Androgens / Q000378:metabolism*; D000818:Animals; D017209:Apoptosis; D014408:Biomarkers, Tumor / Q000378:metabolism; D049109:Cell Proliferation; D004195:Disease Models, Animal; D006801:Humans; D008297:Male; D051379:Mice; D011467:Prostate / Q000378:metabolism* / Q000473:pathology; D011471:Prostatic Neoplasms / Q000473:pathology; D015398:Signal Transduction / Q000502:physiology*; D019737:Transplants; D014407:Tumor Cells, Cultured
D000728:Androgens; D014408:Biomarkers, Tumor
Cancer Cell. 2006 May;9(5):367-78
16697957
Cancer Res. 2006 Mar 1;66(5):2815-25
16510604
J Nutr. 2005 Dec;135(12 Suppl):3009S-3015S
16317162
Nature. 2009 Sep 24;461(7263):495-500
19741607
Curr Med Res Opin. 2007 May;23(5):1077-80
17519074
Prostate. 2003 Feb 15;54(3):212-9
12518326
Clin Adv Hematol Oncol. 2008 Feb;6(2):118-22, 127-32
18347563
Cell Tissue Res. 2008 Jun;332(3):489-98
18386065
J Natl Cancer Inst. 2007 Jan 17;99(2):105-7
17227991
J Biol Chem. 2007 Aug 31;282(35):25790-800
17602165
Cancer Lett. 2009 Jan 18;273(2):177-93
18632203
J Urol. 2005 Feb;173(2):360-72
15643173
Nature. 2008 Dec 11;456(7223):804-8
18946470
J Urol. 2008 Sep;180(3):921-7
18635218
Cancer Res. 2004 Mar 1;64(5):1712-21
14996731
Am J Pathol. 2001 Sep;159(3):855-60
11549578
Am J Surg Pathol. 1994 Oct;18(10):979-91
7522415
Hum Pathol. 2004 Mar;35(3):290-7
15017584
Proc Natl Acad Sci U S A. 2007 Apr 24;104(17):7211-6
17431037
J Clin Pathol. 2008 Apr;61(4):448-54
17720776
Cancer Res. 2004 Mar 15;64(6):2270-305
15026373
Cancer Res. 2008 Jun 1;68(11):4447-54
18519708
Cancer. 2000 Jan 15;88(2):407-15
10640975
Am J Mens Health. 2008 Jun;2(2):178-89
19477782
Prostate. 2004 Jul 1;60(2):77-90
15162374
Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):973-8
17210912
Cancer Res. 2008 Aug 1;68(15):6407-15
18676866
Prostate. 2005 Jul 1;64(2):149-59
15678503
J Urol. 2009 Feb;181(2):615-9; discussion 619-20
19091346
Clin Cancer Res. 2004 Jan 15;10(2):440-8
14760063
J Urol. 2005 Feb;173(2):342-59
15643172
Life Sci. 1995;57(21):1887-901
7475939
J Natl Cancer Inst. 2009 Jan 7;101(1):6-8
19116380
Am J Surg Pathol. 1996 Jan;20(1):86-93
8540613
Blood. 2003 Oct 1;102(7):2522-31
12791667
JAMA. 2005 Jul 13;294(2):238-44
16014598
Br J Dermatol. 1983 Mar;108(3):321-6
6830698
Prostate Cancer Prostatic Dis. 2007;10(2):114-8
17297502
J Urol. 2007 Jun;177(6):2132-5; discussion 2135
17509298
Curr Oncol Rep. 2008 Nov;10(6):529-32
18928669
Prostate. 2008 May 1;68(6):629-39
18213636
BJU Int. 2010 Feb;105(4):462-7
19624594
Mod Pathol. 1996 Oct;9(10):1015-9
8902840
Endocr Relat Cancer. 2005 Mar;12(1):19-47
15788637
J Urol. 2005 Jan;173(1):10-20
15592017